GW&K Investment Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $18.6M | Sell |
|
|||||
|
2024
Q4 | $116M | Sell |
|
|||||
|
2024
Q3 | $102M | Buy |
|
|||||
|
2024
Q2 | $95.5M | Sell |
|
|||||
|
2024
Q1 | $111M | Sell |
|
|||||
|
2023
Q4 | $117M | Sell |
|
|||||
|
2023
Q3 | $88.1M | Sell |
|
|||||
|
2023
Q2 | $109M | Sell |
|
|||||
|
2023
Q1 | $94.9M | Buy |
|
|||||
|
2022
Q4 | $76.8M | Sell |
|
|||||
|
2022
Q3 | $68.2M | Buy |
|
|||||
|
2022
Q2 | $33.3M | Buy |
|
|||||
|
2022
Q1 | $33.6M | Buy |
|
|||||
|
2021
Q4 | $19.5M | Buy |
|